Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 41 | 2024 | 3816 | 7.380 |
Why?
|
Kruppel-Like Transcription Factors | 18 | 2022 | 504 | 3.840 |
Why?
|
Atherosclerosis | 20 | 2024 | 3407 | 3.550 |
Why?
|
Endothelial Cells | 27 | 2023 | 3549 | 3.550 |
Why?
|
Early Growth Response Transcription Factors | 7 | 2022 | 32 | 2.920 |
Why?
|
Neovascularization, Physiologic | 10 | 2023 | 1349 | 2.440 |
Why?
|
Peripheral Arterial Disease | 13 | 2024 | 1273 | 2.270 |
Why?
|
Plaque, Atherosclerotic | 8 | 2024 | 1532 | 1.640 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2023 | 1119 | 1.540 |
Why?
|
Ischemia | 8 | 2023 | 1884 | 1.490 |
Why?
|
Vascular System Injuries | 3 | 2020 | 246 | 1.450 |
Why?
|
MAP Kinase Signaling System | 3 | 2022 | 1486 | 1.340 |
Why?
|
Signal Transduction | 36 | 2024 | 23447 | 1.320 |
Why?
|
Arteries | 3 | 2020 | 1123 | 1.240 |
Why?
|
RNA, Untranslated | 3 | 2021 | 459 | 1.230 |
Why?
|
Myocytes, Smooth Muscle | 8 | 2022 | 699 | 1.210 |
Why?
|
Vasculitis | 5 | 2020 | 521 | 1.200 |
Why?
|
Macrophages | 17 | 2024 | 5767 | 1.190 |
Why?
|
Receptors, LDL | 4 | 2024 | 488 | 1.140 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2020 | 687 | 1.090 |
Why?
|
Diabetic Cardiomyopathies | 2 | 2017 | 90 | 1.030 |
Why?
|
Transforming Growth Factor beta | 10 | 2023 | 1964 | 1.020 |
Why?
|
Cardiovascular Diseases | 10 | 2024 | 15502 | 1.020 |
Why?
|
Animals | 88 | 2024 | 168475 | 1.020 |
Why?
|
NF-kappa B | 9 | 2022 | 2490 | 1.010 |
Why?
|
Neovascularization, Pathologic | 6 | 2021 | 2645 | 1.010 |
Why?
|
Smad1 Protein | 2 | 2016 | 81 | 0.950 |
Why?
|
Diabetic Angiopathies | 3 | 2024 | 803 | 0.950 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2022 | 3080 | 0.940 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5841 | 0.920 |
Why?
|
Succinic Acid | 1 | 2024 | 86 | 0.920 |
Why?
|
Mice | 56 | 2024 | 81539 | 0.910 |
Why?
|
Muscle, Smooth, Vascular | 8 | 2022 | 1492 | 0.900 |
Why?
|
Wound Healing | 3 | 2020 | 2805 | 0.900 |
Why?
|
Mice, Inbred C57BL | 18 | 2024 | 22174 | 0.870 |
Why?
|
Aortic Diseases | 3 | 2024 | 735 | 0.860 |
Why?
|
Gene Expression Regulation | 23 | 2024 | 11904 | 0.850 |
Why?
|
Mice, Knockout | 14 | 2024 | 14417 | 0.840 |
Why?
|
Endothelium, Vascular | 9 | 2022 | 4431 | 0.830 |
Why?
|
Carotid Artery Diseases | 2 | 2021 | 877 | 0.820 |
Why?
|
Serum Response Factor | 2 | 2021 | 78 | 0.770 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 642 | 0.760 |
Why?
|
MAP Kinase Kinase Kinase 4 | 1 | 2020 | 3 | 0.750 |
Why?
|
Tunica Intima | 4 | 2022 | 459 | 0.730 |
Why?
|
Inflammation | 14 | 2022 | 10774 | 0.710 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2020 | 112 | 0.670 |
Why?
|
Antirheumatic Agents | 4 | 2023 | 1373 | 0.670 |
Why?
|
Methotrexate | 4 | 2023 | 1719 | 0.630 |
Why?
|
Monocytes | 9 | 2017 | 2570 | 0.630 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18255 | 0.620 |
Why?
|
Oligonucleotides, Antisense | 3 | 2020 | 461 | 0.620 |
Why?
|
Bone Marrow Cells | 5 | 2013 | 2417 | 0.620 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2022 | 4369 | 0.600 |
Why?
|
Snow | 1 | 2017 | 15 | 0.590 |
Why?
|
RNA, Small Nucleolar | 1 | 2017 | 27 | 0.580 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2016 | 319 | 0.560 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2024 | 1252 | 0.560 |
Why?
|
Insulin Resistance | 4 | 2021 | 3964 | 0.560 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.550 |
Why?
|
Cell Proliferation | 11 | 2022 | 10451 | 0.550 |
Why?
|
Genome, Viral | 1 | 2020 | 667 | 0.550 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2019 | 705 | 0.550 |
Why?
|
Transforming Growth Factor beta1 | 6 | 2011 | 629 | 0.540 |
Why?
|
Myeloid Progenitor Cells | 3 | 2011 | 113 | 0.530 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2872 | 0.520 |
Why?
|
Tamoxifen | 1 | 2020 | 965 | 0.520 |
Why?
|
Oxidative Stress | 2 | 2020 | 3113 | 0.520 |
Why?
|
Adenosine | 1 | 2021 | 808 | 0.520 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2020 | 1246 | 0.510 |
Why?
|
Aorta | 6 | 2022 | 2041 | 0.510 |
Why?
|
Adaptive Immunity | 1 | 2020 | 726 | 0.500 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1023 | 0.500 |
Why?
|
Gene Expression Profiling | 4 | 2022 | 9420 | 0.500 |
Why?
|
Phosphofructokinase-2 | 1 | 2015 | 33 | 0.490 |
Why?
|
Granulocyte-Macrophage Progenitor Cells | 2 | 2011 | 21 | 0.490 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2016 | 159 | 0.480 |
Why?
|
Myocardial Infarction | 8 | 2024 | 11461 | 0.480 |
Why?
|
N-Ethylmaleimide-Sensitive Proteins | 1 | 2014 | 9 | 0.480 |
Why?
|
NF-kappa B p50 Subunit | 2 | 2012 | 103 | 0.480 |
Why?
|
Fatty Liver | 1 | 2020 | 790 | 0.470 |
Why?
|
Humans | 97 | 2024 | 761596 | 0.460 |
Why?
|
RNA, Messenger | 9 | 2022 | 12794 | 0.460 |
Why?
|
Immunologic Memory | 3 | 2020 | 1359 | 0.450 |
Why?
|
Cell Differentiation | 8 | 2022 | 11530 | 0.450 |
Why?
|
Thrombin | 1 | 2016 | 591 | 0.440 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 302 | 0.440 |
Why?
|
Lipoproteins, VLDL | 1 | 2014 | 201 | 0.440 |
Why?
|
Epigenesis, Genetic | 3 | 2021 | 3801 | 0.420 |
Why?
|
Adipose Tissue, White | 1 | 2016 | 365 | 0.420 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 96 | 0.410 |
Why?
|
Cell Nucleus | 2 | 2020 | 2910 | 0.410 |
Why?
|
DNA-Binding Proteins | 12 | 2011 | 9610 | 0.410 |
Why?
|
Coxsackievirus Infections | 1 | 2012 | 42 | 0.400 |
Why?
|
Blood Vessels | 1 | 2018 | 1113 | 0.400 |
Why?
|
Veins | 1 | 2016 | 768 | 0.400 |
Why?
|
Trans-Activators | 8 | 2007 | 2856 | 0.390 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3763 | 0.380 |
Why?
|
Coronary Restenosis | 1 | 2014 | 396 | 0.380 |
Why?
|
Paracrine Communication | 1 | 2013 | 277 | 0.380 |
Why?
|
Myocardial Ischemia | 2 | 2020 | 2113 | 0.380 |
Why?
|
Diabetes Complications | 1 | 2018 | 1315 | 0.380 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12149 | 0.370 |
Why?
|
DNA Damage | 2 | 2020 | 2449 | 0.360 |
Why?
|
Cardiovascular System | 2 | 2017 | 834 | 0.360 |
Why?
|
Apolipoproteins E | 3 | 2013 | 1443 | 0.360 |
Why?
|
Adipose Tissue | 4 | 2020 | 3313 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2457 | 0.350 |
Why?
|
Transcription Factors | 10 | 2023 | 12130 | 0.350 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6403 | 0.350 |
Why?
|
Diabetic Nephropathies | 1 | 2017 | 973 | 0.340 |
Why?
|
Gene Knockdown Techniques | 3 | 2022 | 1612 | 0.340 |
Why?
|
Mechanotransduction, Cellular | 1 | 2015 | 529 | 0.340 |
Why?
|
Cell Line | 14 | 2021 | 15601 | 0.340 |
Why?
|
Myocytes, Cardiac | 5 | 2024 | 1668 | 0.340 |
Why?
|
Wounds, Nonpenetrating | 1 | 2016 | 807 | 0.320 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 842 | 0.300 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 306 | 0.300 |
Why?
|
Obesity | 5 | 2024 | 12947 | 0.300 |
Why?
|
Drug Discovery | 2 | 2017 | 1051 | 0.300 |
Why?
|
Cell Movement | 4 | 2021 | 5205 | 0.280 |
Why?
|
Triglycerides | 2 | 2014 | 2461 | 0.270 |
Why?
|
Ventricular Remodeling | 1 | 2014 | 1267 | 0.270 |
Why?
|
Chemotaxis | 2 | 2024 | 598 | 0.270 |
Why?
|
Vaccinia virus | 1 | 2008 | 331 | 0.270 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2014 | 2118 | 0.270 |
Why?
|
Cytokines | 8 | 2022 | 7396 | 0.260 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1616 | 0.260 |
Why?
|
Male | 40 | 2024 | 360846 | 0.260 |
Why?
|
Homeostasis | 2 | 2021 | 3323 | 0.260 |
Why?
|
Leukocytes | 2 | 2012 | 2026 | 0.260 |
Why?
|
Cells, Cultured | 10 | 2024 | 18966 | 0.250 |
Why?
|
Leukocytes, Mononuclear | 3 | 2022 | 1844 | 0.250 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2811 | 0.250 |
Why?
|
Vascular Diseases | 1 | 2013 | 1161 | 0.250 |
Why?
|
Myocardium | 2 | 2022 | 4725 | 0.240 |
Why?
|
Smad Proteins | 1 | 2005 | 156 | 0.240 |
Why?
|
Stem Cells | 2 | 2020 | 3524 | 0.240 |
Why?
|
Aging | 1 | 2024 | 8710 | 0.240 |
Why?
|
Myocarditis | 1 | 2012 | 788 | 0.240 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2008 | 1351 | 0.240 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3492 | 0.230 |
Why?
|
Antigen Presentation | 2 | 2008 | 1251 | 0.230 |
Why?
|
Transcription Factor RelA | 2 | 2021 | 254 | 0.230 |
Why?
|
Smad3 Protein | 5 | 2005 | 166 | 0.230 |
Why?
|
Silk | 1 | 2024 | 90 | 0.220 |
Why?
|
Energy Metabolism | 1 | 2015 | 2882 | 0.220 |
Why?
|
Macrophage Activation | 6 | 2008 | 553 | 0.220 |
Why?
|
Gene Silencing | 3 | 2020 | 1509 | 0.210 |
Why?
|
Transforming Growth Factors | 1 | 2022 | 75 | 0.210 |
Why?
|
Factor X | 1 | 2022 | 64 | 0.210 |
Why?
|
Regional Blood Flow | 2 | 2020 | 1496 | 0.210 |
Why?
|
Inhibins | 1 | 2023 | 210 | 0.210 |
Why?
|
Muscle, Skeletal | 5 | 2022 | 4948 | 0.200 |
Why?
|
RNA | 2 | 2022 | 2725 | 0.200 |
Why?
|
Interleukin-9 | 1 | 2022 | 62 | 0.200 |
Why?
|
Genetic Markers | 2 | 2020 | 2601 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8540 | 0.200 |
Why?
|
Arteriosclerosis | 5 | 2007 | 1055 | 0.190 |
Why?
|
RNA, Small Interfering | 4 | 2023 | 3430 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2015 | 4580 | 0.190 |
Why?
|
Chemokine CCL2 | 1 | 2004 | 605 | 0.190 |
Why?
|
Blood Glucose | 1 | 2016 | 6391 | 0.190 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2020 | 11 | 0.180 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.180 |
Why?
|
Neutrophils | 1 | 2013 | 3767 | 0.170 |
Why?
|
Swine | 2 | 2020 | 5915 | 0.170 |
Why?
|
Phosphorylation | 4 | 2019 | 8321 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 126 | 0.170 |
Why?
|
Complement Activation | 1 | 2022 | 445 | 0.170 |
Why?
|
Fibroblasts | 3 | 2016 | 4142 | 0.170 |
Why?
|
I-kappa B Kinase | 1 | 2021 | 250 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 2 | 2020 | 2805 | 0.170 |
Why?
|
Promoter Regions, Genetic | 11 | 2011 | 5790 | 0.170 |
Why?
|
Metalloendopeptidases | 2 | 2000 | 393 | 0.170 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 546 | 0.170 |
Why?
|
Sus scrofa | 1 | 2021 | 428 | 0.170 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2019 | 22 | 0.160 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2022 | 542 | 0.160 |
Why?
|
Hindlimb | 2 | 2011 | 513 | 0.160 |
Why?
|
Angiotensin II | 1 | 2022 | 849 | 0.160 |
Why?
|
Medicare | 4 | 2024 | 6770 | 0.160 |
Why?
|
Repressor Proteins | 3 | 2004 | 2986 | 0.160 |
Why?
|
Necrosis | 1 | 2023 | 1611 | 0.160 |
Why?
|
Inflammation Mediators | 3 | 2018 | 1886 | 0.160 |
Why?
|
Hydrogels | 1 | 2024 | 720 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
Gene Targeting | 1 | 2021 | 838 | 0.150 |
Why?
|
Angiogenic Proteins | 1 | 2018 | 101 | 0.150 |
Why?
|
Intermittent Claudication | 1 | 2020 | 304 | 0.150 |
Why?
|
Interleukin-10 | 2 | 2022 | 1175 | 0.150 |
Why?
|
Ebola Vaccines | 1 | 2017 | 24 | 0.150 |
Why?
|
Organ Culture Techniques | 1 | 2020 | 795 | 0.140 |
Why?
|
Retinal Diseases | 1 | 2023 | 705 | 0.140 |
Why?
|
Nitric Oxide Synthase Type II | 5 | 2007 | 517 | 0.140 |
Why?
|
Hypercholesterolemia | 2 | 2021 | 1141 | 0.140 |
Why?
|
Glucose | 3 | 2021 | 4347 | 0.140 |
Why?
|
Species Specificity | 2 | 2020 | 2414 | 0.140 |
Why?
|
Lipopolysaccharides | 5 | 2021 | 2206 | 0.140 |
Why?
|
Dendritic Cells | 1 | 2008 | 2747 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1096 | 0.140 |
Why?
|
Autoimmune Diseases | 2 | 2021 | 2244 | 0.140 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 871 | 0.140 |
Why?
|
Codon, Terminator | 1 | 2017 | 124 | 0.140 |
Why?
|
Congresses as Topic | 1 | 2021 | 803 | 0.140 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 583 | 0.130 |
Why?
|
Cell Cycle Proteins | 4 | 2023 | 3449 | 0.130 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2112 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2023 | 4352 | 0.130 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2016 | 47 | 0.130 |
Why?
|
Viral Proteins | 2 | 2020 | 1804 | 0.130 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 983 | 0.130 |
Why?
|
Carotid Arteries | 2 | 2017 | 941 | 0.130 |
Why?
|
Arthritis | 1 | 2021 | 680 | 0.130 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 764 | 0.130 |
Why?
|
Oxygen | 2 | 2024 | 4227 | 0.130 |
Why?
|
Neoplasms | 2 | 2022 | 22173 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1745 | 0.120 |
Why?
|
Female | 22 | 2024 | 392705 | 0.120 |
Why?
|
Transfection | 7 | 2007 | 5774 | 0.120 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 148 | 0.120 |
Why?
|
American Heart Association | 1 | 2020 | 1039 | 0.120 |
Why?
|
Immune System | 1 | 2020 | 796 | 0.120 |
Why?
|
Research Personnel | 1 | 2020 | 588 | 0.120 |
Why?
|
Mice, Obese | 1 | 2016 | 420 | 0.120 |
Why?
|
Ebolavirus | 1 | 2017 | 251 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8554 | 0.120 |
Why?
|
Protein Transport | 1 | 2020 | 1967 | 0.120 |
Why?
|
Fibrosis | 1 | 2022 | 2049 | 0.120 |
Why?
|
Gene Deletion | 2 | 2017 | 2665 | 0.120 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2016 | 97 | 0.120 |
Why?
|
Immunoprecipitation | 1 | 2017 | 878 | 0.120 |
Why?
|
Dermis | 1 | 2016 | 202 | 0.120 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1827 | 0.120 |
Why?
|
Phenotype | 3 | 2021 | 16592 | 0.120 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 2001 | 1784 | 0.120 |
Why?
|
Transcription, Genetic | 8 | 2021 | 7593 | 0.120 |
Why?
|
Peptide Fragments | 3 | 2021 | 5112 | 0.110 |
Why?
|
Disease Progression | 4 | 2023 | 13510 | 0.110 |
Why?
|
Estrogens | 1 | 2020 | 1522 | 0.110 |
Why?
|
Gap Junctions | 1 | 2015 | 230 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1188 | 0.110 |
Why?
|
Critical Illness | 2 | 2020 | 2723 | 0.110 |
Why?
|
Receptors, CCR4 | 1 | 2013 | 77 | 0.110 |
Why?
|
Computer-Aided Design | 1 | 2015 | 300 | 0.110 |
Why?
|
Karyopherins | 1 | 2013 | 133 | 0.110 |
Why?
|
Transcription Factor AP-1 | 3 | 2006 | 321 | 0.100 |
Why?
|
Protein Kinases | 1 | 2020 | 1608 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2684 | 0.100 |
Why?
|
Nitric Oxide Synthase | 4 | 2004 | 908 | 0.100 |
Why?
|
Models, Biological | 3 | 2020 | 9469 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15843 | 0.100 |
Why?
|
alpha Karyopherins | 1 | 2012 | 40 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1723 | 0.100 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 420 | 0.100 |
Why?
|
Risk Factors | 7 | 2024 | 74213 | 0.100 |
Why?
|
E-Selectin | 2 | 2012 | 576 | 0.100 |
Why?
|
Gene Expression | 3 | 2016 | 7581 | 0.100 |
Why?
|
Culture Media, Conditioned | 1 | 2013 | 522 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 555 | 0.090 |
Why?
|
Epidemics | 1 | 2017 | 512 | 0.090 |
Why?
|
Lipoproteins | 1 | 2016 | 881 | 0.090 |
Why?
|
Antigens, CD34 | 1 | 2013 | 658 | 0.090 |
Why?
|
Endotoxemia | 1 | 2012 | 196 | 0.090 |
Why?
|
Blood Sedimentation | 2 | 2022 | 235 | 0.090 |
Why?
|
Structure-Activity Relationship | 2 | 2015 | 3076 | 0.090 |
Why?
|
Molecular Structure | 1 | 2015 | 1880 | 0.090 |
Why?
|
Time Factors | 9 | 2024 | 39969 | 0.090 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1902 | 0.090 |
Why?
|
Muscle Proteins | 3 | 2002 | 1154 | 0.090 |
Why?
|
Apoptosis | 3 | 2020 | 9490 | 0.090 |
Why?
|
Bone Marrow Transplantation | 2 | 2019 | 2693 | 0.090 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 691 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2242 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 733 | 0.080 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 3 | 2004 | 26 | 0.080 |
Why?
|
Hemodynamics | 1 | 2020 | 4160 | 0.080 |
Why?
|
T-Lymphocytes | 4 | 2008 | 10194 | 0.080 |
Why?
|
Mast Cells | 1 | 2016 | 1392 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3517 | 0.080 |
Why?
|
Embryonic Development | 1 | 2013 | 721 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2012 | 367 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2917 | 0.080 |
Why?
|
Liver | 2 | 2021 | 7528 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 3066 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 844 | 0.080 |
Why?
|
Receptors, Prostaglandin E | 1 | 2008 | 56 | 0.080 |
Why?
|
p300-CBP Transcription Factors | 2 | 2006 | 150 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1898 | 0.070 |
Why?
|
Nucleoproteins | 1 | 2008 | 113 | 0.070 |
Why?
|
Aspirin | 1 | 2019 | 3133 | 0.070 |
Why?
|
Smallpox Vaccine | 1 | 2008 | 77 | 0.070 |
Why?
|
RNA Interference | 1 | 2016 | 2832 | 0.070 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 2004 | 286 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2751 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3624 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2011 | 1341 | 0.070 |
Why?
|
Hematopoietic System | 1 | 2007 | 110 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.070 |
Why?
|
HLA-A2 Antigen | 2 | 1998 | 211 | 0.070 |
Why?
|
Protein Binding | 4 | 2008 | 9353 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1303 | 0.070 |
Why?
|
Interferon-gamma | 3 | 2005 | 3162 | 0.070 |
Why?
|
Middle Aged | 12 | 2024 | 220921 | 0.070 |
Why?
|
Receptors, CXCR3 | 1 | 2007 | 238 | 0.070 |
Why?
|
Chick Embryo | 1 | 2008 | 982 | 0.070 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2001 | 541 | 0.070 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2005 | 1725 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 422 | 0.060 |
Why?
|
Rats | 4 | 2024 | 23741 | 0.060 |
Why?
|
Risk Assessment | 5 | 2024 | 23996 | 0.060 |
Why?
|
Blotting, Western | 2 | 2005 | 5035 | 0.060 |
Why?
|
Transcriptional Activation | 3 | 2007 | 1756 | 0.060 |
Why?
|
Nitrites | 1 | 2005 | 159 | 0.060 |
Why?
|
Simian immunodeficiency virus | 2 | 2001 | 809 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58984 | 0.060 |
Why?
|
Digitalis | 1 | 2004 | 14 | 0.060 |
Why?
|
Digitoxin | 1 | 2004 | 19 | 0.060 |
Why?
|
Plant Poisoning | 1 | 2004 | 13 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2007 | 662 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10766 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5439 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1600 | 0.060 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2005 | 277 | 0.060 |
Why?
|
Aged | 9 | 2024 | 169310 | 0.060 |
Why?
|
Binding Sites | 2 | 2005 | 6056 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4544 | 0.060 |
Why?
|
Gangrene | 1 | 2024 | 91 | 0.060 |
Why?
|
Matrix Metalloproteinase 12 | 2 | 2000 | 44 | 0.060 |
Why?
|
Thrombosis | 2 | 2016 | 2942 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 4576 | 0.060 |
Why?
|
DNA | 3 | 2007 | 7213 | 0.060 |
Why?
|
Blotting, Northern | 1 | 2005 | 1545 | 0.060 |
Why?
|
Cell Separation | 1 | 2009 | 1720 | 0.060 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2023 | 89 | 0.050 |
Why?
|
Up-Regulation | 3 | 2021 | 4125 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2008 | 1869 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2567 | 0.050 |
Why?
|
Genetic Testing | 1 | 2016 | 3537 | 0.050 |
Why?
|
Bradycardia | 1 | 2004 | 299 | 0.050 |
Why?
|
HIV Antigens | 3 | 1998 | 325 | 0.050 |
Why?
|
Tissue Adhesives | 1 | 2024 | 173 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2023 | 6312 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2023 | 2264 | 0.050 |
Why?
|
Chemokine CXCL12 | 1 | 2024 | 454 | 0.050 |
Why?
|
Complement Membrane Attack Complex | 1 | 2022 | 105 | 0.050 |
Why?
|
Zebrafish | 1 | 2013 | 3008 | 0.050 |
Why?
|
Ventricular Function, Left | 2 | 2013 | 3879 | 0.050 |
Why?
|
Adiponectin | 1 | 2007 | 1113 | 0.050 |
Why?
|
Biology | 1 | 2023 | 290 | 0.050 |
Why?
|
Down-Regulation | 2 | 2005 | 2919 | 0.050 |
Why?
|
RNA, Small Untranslated | 1 | 2021 | 77 | 0.050 |
Why?
|
Injections | 1 | 2024 | 831 | 0.050 |
Why?
|
Cardiotonic Agents | 1 | 2024 | 539 | 0.050 |
Why?
|
Anti-Obesity Agents | 1 | 2024 | 227 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2010 | 2050 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2002 | 1693 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2002 | 436 | 0.040 |
Why?
|
Hyperplasia | 1 | 2004 | 1152 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 2190 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2004 | 1529 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1668 | 0.040 |
Why?
|
High Mobility Group Proteins | 1 | 2001 | 177 | 0.040 |
Why?
|
Lymphocyte Activation | 3 | 2008 | 5485 | 0.040 |
Why?
|
HIV Seropositivity | 2 | 2017 | 960 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 173 | 0.040 |
Why?
|
Enzyme Induction | 1 | 2000 | 452 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 2004 | 4807 | 0.040 |
Why?
|
Integrins | 1 | 2004 | 834 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3826 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2004 | 1126 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15266 | 0.040 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5799 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2020 | 1171 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2021 | 451 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17904 | 0.040 |
Why?
|
Databases, Factual | 2 | 2024 | 7968 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2009 | 5870 | 0.040 |
Why?
|
HIV-1 | 4 | 1998 | 6863 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 3733 | 0.040 |
Why?
|
Antigenic Variation | 1 | 1998 | 118 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3792 | 0.040 |
Why?
|
Cell Lineage | 1 | 2007 | 2557 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2008 | 3396 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3810 | 0.040 |
Why?
|
HLA-A Antigens | 1 | 1998 | 223 | 0.040 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 1996 | 225 | 0.040 |
Why?
|
Endothelium | 1 | 2021 | 765 | 0.040 |
Why?
|
HIV Long-Term Survivors | 1 | 1998 | 121 | 0.040 |
Why?
|
Gene Products, gag | 1 | 1998 | 312 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 858 | 0.040 |
Why?
|
United States | 5 | 2024 | 72340 | 0.040 |
Why?
|
Amino Acid Sequence | 8 | 2004 | 13446 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 780 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2000 | 852 | 0.040 |
Why?
|
Vesiculovirus | 1 | 2017 | 55 | 0.040 |
Why?
|
Liberia | 1 | 2017 | 174 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2017 | 223 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2002 | 1069 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16990 | 0.040 |
Why?
|
Molecular Sequence Data | 8 | 2004 | 17635 | 0.030 |
Why?
|
Epitopes | 3 | 1998 | 2503 | 0.030 |
Why?
|
Microfilament Proteins | 2 | 2002 | 1134 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 1999 | 532 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9542 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2023 | 916 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 368 | 0.030 |
Why?
|
P-Selectin | 1 | 1999 | 597 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2017 | 554 | 0.030 |
Why?
|
Neural Crest | 1 | 1998 | 279 | 0.030 |
Why?
|
Advisory Committees | 1 | 2020 | 787 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2020 | 697 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1814 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 22176 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1202 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4514 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2178 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1601 | 0.030 |
Why?
|
DNA Primers | 4 | 2004 | 2820 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1999 | 1435 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2024 | 64685 | 0.030 |
Why?
|
Plasmids | 1 | 2019 | 2269 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 1998 | 926 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2022 | 4853 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3683 | 0.030 |
Why?
|
Stents | 1 | 2005 | 3179 | 0.030 |
Why?
|
Adenoviridae | 1 | 2017 | 1085 | 0.030 |
Why?
|
Walking | 1 | 2020 | 1198 | 0.030 |
Why?
|
RNA, Viral | 2 | 2017 | 2846 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2382 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1999 | 1349 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2002 | 130 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2022 | 3208 | 0.020 |
Why?
|
Base Sequence | 5 | 2004 | 12441 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4281 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 5914 | 0.020 |
Why?
|
Heart Failure | 1 | 2015 | 11671 | 0.020 |
Why?
|
Cercocebus atys | 2 | 2001 | 12 | 0.020 |
Why?
|
Electrocardiography | 2 | 2004 | 6377 | 0.020 |
Why?
|
3T3 Cells | 2 | 2002 | 1085 | 0.020 |
Why?
|
Stress, Mechanical | 2 | 2007 | 1674 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2226 | 0.020 |
Why?
|
Communicable Disease Control | 1 | 2017 | 846 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3233 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4793 | 0.020 |
Why?
|
Fever | 1 | 2017 | 1618 | 0.020 |
Why?
|
Age Factors | 2 | 2024 | 18399 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2046 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1256 | 0.020 |
Why?
|
Phagocytosis | 2 | 2006 | 1528 | 0.020 |
Why?
|
Zinc Fingers | 2 | 2004 | 579 | 0.020 |
Why?
|
Interleukin-1 | 2 | 2004 | 1248 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 3617 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2007 | 3088 | 0.020 |
Why?
|
Mutation | 2 | 2005 | 30053 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6032 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4415 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.020 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2008 | 44 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4937 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1749 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7048 | 0.020 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2008 | 92 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13255 | 0.020 |
Why?
|
Heart Rate | 1 | 2019 | 4195 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 3612 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 12953 | 0.020 |
Why?
|
Thrombomodulin | 1 | 2007 | 105 | 0.020 |
Why?
|
Carrageenan | 1 | 2006 | 71 | 0.020 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2008 | 332 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6597 | 0.020 |
Why?
|
Heart | 1 | 1998 | 4404 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2024 | 80647 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 931 | 0.020 |
Why?
|
New Jersey | 1 | 2005 | 295 | 0.020 |
Why?
|
Dinoprostone | 1 | 2008 | 597 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4399 | 0.010 |
Why?
|
Cardiac Tamponade | 1 | 2005 | 175 | 0.010 |
Why?
|
Sleep, REM | 1 | 1987 | 595 | 0.010 |
Why?
|
Medical Audit | 1 | 2005 | 453 | 0.010 |
Why?
|
HIV Reverse Transcriptase | 2 | 1996 | 212 | 0.010 |
Why?
|
Histone Acetyltransferases | 1 | 2006 | 336 | 0.010 |
Why?
|
HL-60 Cells | 1 | 2004 | 363 | 0.010 |
Why?
|
Macaca mulatta | 2 | 2001 | 2329 | 0.010 |
Why?
|
Chemokines | 1 | 2008 | 959 | 0.010 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 285 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2004 | 426 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8481 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12341 | 0.010 |
Why?
|
Digoxin | 1 | 2004 | 246 | 0.010 |
Why?
|
Israel | 1 | 2005 | 726 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2004 | 817 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4176 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2004 | 670 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 102 | 0.010 |
Why?
|
Nuclear Matrix | 1 | 2002 | 30 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2002 | 103 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 135 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 240 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2002 | 6534 | 0.010 |
Why?
|
Immunity | 1 | 2007 | 996 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12690 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2001 | 153 | 0.010 |
Why?
|
Syncope | 1 | 2004 | 427 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 15633 | 0.010 |
Why?
|
Nausea | 1 | 2004 | 679 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 2 | 1998 | 2571 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6075 | 0.010 |
Why?
|
Vomiting | 1 | 2004 | 651 | 0.010 |
Why?
|
Viral Load | 2 | 2001 | 3332 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2002 | 255 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
Fibrinogen | 1 | 2004 | 888 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2007 | 1154 | 0.010 |
Why?
|
Mice, SCID | 1 | 2006 | 2626 | 0.010 |
Why?
|
HMGA1a Protein | 1 | 2001 | 61 | 0.010 |
Why?
|
Interferon Regulatory Factors | 1 | 2002 | 261 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 850 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2748 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2004 | 1494 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41495 | 0.010 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2001 | 296 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2002 | 618 | 0.010 |
Why?
|
HIV Infections | 2 | 1996 | 17354 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1991 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2005 | 1301 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2005 | 1166 | 0.010 |
Why?
|
Leucine Zippers | 1 | 1998 | 116 | 0.010 |
Why?
|
L-Selectin | 1 | 1998 | 209 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1999 | 436 | 0.010 |
Why?
|
HeLa Cells | 1 | 2004 | 3094 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 420 | 0.010 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 206 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2001 | 828 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 1998 | 562 | 0.010 |
Why?
|
Proviruses | 1 | 1998 | 313 | 0.010 |
Why?
|
Neutralization Tests | 1 | 1998 | 728 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 1130 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 866 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 2188 | 0.010 |
Why?
|
Zalcitabine | 1 | 1996 | 43 | 0.010 |
Why?
|
Myosin Heavy Chains | 1 | 1998 | 405 | 0.010 |
Why?
|
Didanosine | 1 | 1996 | 151 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2391 | 0.010 |
Why?
|
Adult | 3 | 2021 | 221210 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3779 | 0.010 |
Why?
|
Adipocytes | 1 | 2002 | 1194 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3272 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1996 | 298 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1998 | 909 | 0.010 |
Why?
|
Depressive Disorder | 1 | 1987 | 3728 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1998 | 1900 | 0.010 |
Why?
|
Lamivudine | 1 | 1996 | 366 | 0.010 |
Why?
|
Cross Reactions | 1 | 1996 | 817 | 0.010 |
Why?
|
Collagen | 1 | 2001 | 2638 | 0.010 |
Why?
|
Viremia | 1 | 1996 | 707 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 1996 | 825 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1996 | 1163 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3442 | 0.010 |
Why?
|
Cholesterol | 1 | 2001 | 2905 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12059 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2001 | 2448 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2005 | 5293 | 0.010 |
Why?
|
Deoxycytidine | 1 | 1996 | 877 | 0.010 |
Why?
|
Virus Replication | 1 | 1998 | 2435 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1998 | 1802 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 1987 | 5092 | 0.010 |
Why?
|
Oligopeptides | 1 | 1996 | 1187 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8181 | 0.010 |
Why?
|
DNA, Viral | 1 | 1996 | 2202 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12973 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1999 | 4471 | 0.000 |
Why?
|
Echocardiography | 1 | 1999 | 4989 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12723 | 0.000 |
Why?
|
Antiviral Agents | 1 | 1996 | 3060 | 0.000 |
Why?
|
Reaction Time | 1 | 1987 | 2089 | 0.000 |
Why?
|
Prospective Studies | 1 | 2005 | 54423 | 0.000 |
Why?
|
Genetic Variation | 1 | 1996 | 6567 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1987 | 6019 | 0.000 |
Why?
|
Electroencephalography | 1 | 1987 | 6237 | 0.000 |
Why?
|